Fluorodeoxyglucose

DRUG2 trials

Sponsors

Yale University, Indiana University

Conditions

Alzheimer DiseaseEarly Onset Alzheimer DiseaseMild Cognitive ImpairmentSarcoidosis

Early Phase 1

Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82

CompletedNCT03048097

Yale UniversitySarcoidosis

Start: 2017-02-01End: 2018-07-02Updated: 2019-08-26

Unknown Phase

Longitudinal Early-onset Alzheimer's Disease Study Protocol

RecruitingNCT03507257

Indiana UniversityAlzheimer Disease, Early Onset Alzheimer Disease, Mild Cognitive Impairment

Start: 2018-04-30End: 2026-05-31Target: 850Updated: 2026-02-18